HITshow Daily: October 2, 2025 (Thursday)
Podcast: Play in new window | Download (Duration: 9:11 — 12.6MB) | Embed
Today on HITshow:
Today’s top story: the federal shutdown is more than politics — Teresa Vaughn walks providers through a detailed checklist on compliance, telehealth, hospital-at-home, finance, and research. Also: UnitedHealth hires Duke’s AI leader as Chief Scientist, Hackensack pairs dogs with AI for cancer detection, Omada launches a nutrition AI for chronic care, and the federal government calls on Eli Lilly and Pfizer to boost production of key drugs.
HOST: Steve Daily
📍 Providers / Government — Teresa Vaughn
The shutdown fallout is hitting operations: CMS survey triage, telehealth flex expirations, Hospital-at-Home pause, and looming safety-net cuts. Vaughn shares the following checklist for health system leaders:
- Quality & Compliance: Focus on IJ, EMTALA, dialysis.
- Access & Scheduling: Update telehealth workflows for therapy and mental health.
- Capacity: Reallocate staff and beds with Hospital-at-Home paused.
- Finance: Model DSH and rural add-on reductions through Q4.
- Community: Coordinate with FQHCs to smooth referrals.
- Innovation & Research: Expect device and grant delays; adjust timelines.
📍 AI & Payers — Jade Romero
UnitedHealth names Duke’s Michael Pencina as Chief AI Scientist, signaling a credibility-first push to scale responsible AI.
📍 Providers / Research — Logan Stokes
Hackensack Meridian partners with Israel-based startup SpotitEarly to validate canine scent + AI for early cancer detection — a message to providers that bold research can be a differentiator.
📍 Digital Health — Nate Collier
Omada Health debuts “Meal Map,” an AI nutrition tool for cardiometabolic patients — early pilots show engagement gains.
📍 Pharma & Policy — Peter Betterworth
The administration asks Eli Lilly to ramp production of insulin, and Pfizer to increase productoin of Ibrance, and Lipitor — raising supply and formulary planning questions for hospitals.
🎧 Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show.
HITshow is made possible by HLTH 2025.
